{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:12:42Z","timestamp":1789132362643,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaacap.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jaac.2021.03.021","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T06:20:40Z","timestamp":1620109240000},"page":"243-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1837-4126","authenticated-orcid":false,"given":"Melissa P.","family":"DelBello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2777-2361","authenticated-orcid":false,"given":"Aditi","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9760-2152","authenticated-orcid":false,"given":"Rajpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1389-1474","authenticated-orcid":false,"given":"Katsuhiko","family":"Hagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-8647","authenticated-orcid":false,"given":"Antony","family":"Loebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2021.03.021_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40272-013-0022-8","article-title":"Bipolar depression in pediatric populations: epidemiology and management","volume":"15","author":"Cosgrove","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaac.2021.03.021_bib2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.63.10.1139","article-title":"Phenomenology of children and adolescents with bipolar spectrum disorders","volume":"63","author":"Axelson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib3","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4088\/JCP.09m05835yel","article-title":"Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results","volume":"71","author":"Horwitz","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib4","first-page":"397","article-title":"Pediatric bipolar disorder versus severe mood dysregulation: risk for manic episodes on follow-up","volume":"49","author":"Stringaris","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/appi.ajp.2009.08101569","article-title":"Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study","volume":"166","author":"Birmaher","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/01.chi.0000170554.23422.c1","article-title":"Pediatric bipolar disorder: a review of the past 10 years","volume":"44","author":"Pavuluri","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(11)60512-6","article-title":"Global burden of disease in young people aged 10\u201324 years: a systematic analysis","volume":"377","author":"Gore","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2021.03.021_bib8","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2008-0841","article-title":"Quality of life in pediatric bipolar disorder","volume":"123","author":"Freeman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2021.03.021_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jad.2013.05.039","article-title":"What goes up must come down: the burden of bipolar depression in youth","volume":"150","author":"Van Meter","year":"2013","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2021.03.021_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1399-5618.2005.00263.x","article-title":"History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk","volume":"7","author":"Goldstein","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2021.03.021_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-1781(97)00109-1","article-title":"Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania","volume":"73","author":"Dilsaver","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jaac.2021.03.021_bib14","doi-asserted-by":"crossref","unstructured":"DelBello MP, Goldman R, Tocco M, et\u00a0al. Efficacy and safety of lurasidone in children and adolescents with bipolar depression: results from a 2-year open-label extension study. Presented at: APA Annual Meeting; May 18\u221223, 2019; San Francisco.","DOI":"10.1016\/j.euroneuro.2019.09.349"},{"key":"10.1016\/j.jaac.2021.03.021_bib15","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2021.03.021_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.jaac.2021.03.021_bib17","author":"Higgins"},{"key":"10.1016\/j.jaac.2021.03.021_bib18","author":"Poznanski"},{"key":"10.1016\/j.jaac.2021.03.021_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/cap.2010.0063","article-title":"Psychometric properties of the Children\u2019s Depression Rating Scale\u2212Revised in adolescents","volume":"20","author":"Mayes","year":"2010","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2021.03.021_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jaac.2021.03.021_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jad.2013.10.040","article-title":"Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"155","author":"Citrome","year":"2014","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2021.03.021_bib22","author":"Sch\u00fcnemann"},{"key":"10.1016\/j.jaac.2021.03.021_bib23","unstructured":"Dias S, Welton NJ, Sutton AJ, Ades AE. NICE DSU Technical Support Document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. Accessed August 13, 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK310366\/pdf\/Bookshelf_NBK310366.pdf"},{"key":"10.1016\/j.jaac.2021.03.021_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2","volume":"14","author":"Hoaglin","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jaac.2021.03.021_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/cap.2013.0105","article-title":"Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial","volume":"24","author":"Findling","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2021.03.021_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2009.00728.x","article-title":"A\u00a0double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder","volume":"11","author":"DelBello","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2021.03.021_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for\u00a0presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaac.2021.03.021_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaac.2017.10.006","article-title":"Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: a double-blind, placebo-controlled study","volume":"56","author":"DelBello","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaac.2014.12.012","article-title":"Olanzapine\/fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial","volume":"54","author":"Detke","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chc.2005.08.007","article-title":"Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents","volume":"15","author":"Correll","year":"2006","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2021.03.021_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00787-013-0399-5","article-title":"Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review","volume":"22","author":"Mart\u00ednez-Ortega","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1542\/peds.111.1.67","article-title":"Overeating among adolescents: prevalence and associations with weight-related characteristics and psychological health","volume":"111","author":"Ackard","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2021.03.021_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10567-010-0072-1","article-title":"The relation between eating- and weight-related disturbances and depression in adolescence: a review","volume":"13","author":"Rawana","year":"2010","journal-title":"Clin Child Fam Psychol Rev"},{"key":"10.1016\/j.jaac.2021.03.021_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MLR.0b013e318040ad90","article-title":"Factors that affect adherence to bipolar disorder treatments: a stated-preference approach","volume":"45","author":"Johnson","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.jaac.2021.03.021_bib37","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1111\/jocn.13802","article-title":"Overweight or obesity in children aged 0 to 6 and the risk of adult metabolic syndrome: a systematic review and meta-analysis","volume":"26","author":"Kim","year":"2017","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.jaac.2021.03.021_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/15622975.2017.1285050","article-title":"Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: a systematic review and network meta-analysis","volume":"19","author":"Ostacher","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12991-017-0159-x","article-title":"Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records","volume":"16","author":"Meyer","year":"2017","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.jaac.2021.03.021_bib41","first-page":"26","article-title":"Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents","volume":"69","author":"Correll","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2021.03.021_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856721002719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856721002719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T06:12:54Z","timestamp":1723097574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856721002719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0890856721002719"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2021.03.021","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2021.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}